INDICE: List of contributors Preface Chapter 1 Similarities and differencesin the pathophysiology of asthma and COPD J. Christian Virchow Chapter 2 Glucocorticoids: pharmacology and mechanisms Peter J. Barnes Chapter 3 Inhaled corticosteroids: clinical effects in asthma and COPD Paul M. O'Byrne and Desmond M. Murphy Chapter 4 LABAS: pharmacology, mechanisms and interaction with anti-inflammatory treatments Gary P. Anderson Chapter 5 Long and ultra-long-acting ß2-agonists Mario Cazzola and Maria Gabriella Matera Chapter 6 The safety of long-acting beta-agonists and the development of combination therapies for asthma and COPD Victor E. Ortega and Eugene R. Bleecker Chapter 7 Inhaled combination therapy with glucocorticoids and long-acting ß2-agonists in asthma and COPD, current and future perspectives Jan Lötvall Chapter 8 Novel anti-inflammatory treatments for asthma and COPD Paul A. Kirkham, Gaetano Caramori, K. Fan Chung and Ian M. Adcock Chapter 9 Novel biologicals alone and in combination inasthma and allergy Sharmilee M. Nyenhuis and William W. Busse Chapter 10 Anti-infective treatments in asthma and COPD Jonathan D.R. Macintyre and SebastianL. Johnston Chapter 11 Long-acting muscarinic antagonists in asthma and COPD M. Diane Lougheed, Josuel Ora and Denis E. O'Donnell Chapter 12 Phosphodiesterase inhibitors in obstructive lung disease Jan Lötvall and Bo Lundbäck Chapter13 Biological therapies in development for COPD J. Morjaria and R. Polosa Chapter 14 'Triple therapy' in the management of COPD: inhaled steroid, long-acting anticholinergic and long-acting ß2-agonist Ronald Dahl
- ISBN: 978-0-470-72702-7
- Editorial: John Wiley & Sons
- Encuadernacion: Cartoné
- Páginas: 368
- Fecha Publicación: 16/12/2011
- Nº Volúmenes: 1
- Idioma: Inglés